Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers - PubMed (original) (raw)
. 1992 Aug 19;84(16):1279-82.
doi: 10.1093/jnci/84.16.1279.
Affiliations
- PMID: 1353538
- DOI: 10.1093/jnci/84.16.1279
Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers
D R Ciocca et al. J Natl Cancer Inst. 1992.
No abstract available
Comment in
- Relationship among prognostic laboratory indices in breast cancers.
Miller JM, Debari VA, Rubin AD, Todd DM. Miller JM, et al. J Natl Cancer Inst. 1992 Dec 2;84(23):1833-5. doi: 10.1093/jnci/84.23.1833-a. J Natl Cancer Inst. 1992. PMID: 1359157 No abstract available.
Similar articles
- HER-2/neu oncogene expression and proliferation in breast cancers.
Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW. Bacus SS, et al. Am J Pathol. 1990 Jul;137(1):103-11. Am J Pathol. 1990. PMID: 1973597 Free PMC article. - Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP, Strickler JG. Singleton TP, et al. Pathol Annu. 1992;27 Pt 1:165-90. Pathol Annu. 1992. PMID: 1346551 Review. - Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
Knyazev PG, Imyanitov EN, Chernitca OI, Nikiforova IF, Hanson KP. Knyazev PG, et al. Oncology. 1992;49(2):162-5. doi: 10.1159/000227032. Oncology. 1992. PMID: 1349430 - HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP. Tiwari RK, et al. Anticancer Res. 1992 Mar-Apr;12(2):419-25. Anticancer Res. 1992. PMID: 1349794 - Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
Maguire HC Jr, Greene MI. Maguire HC Jr, et al. Pathobiology. 1990;58(6):297-303. doi: 10.1159/000163601. Pathobiology. 1990. PMID: 1981830 Review.
Cited by
- Biological indices in the assessment of breast cancer.
Leong AS, Lee AK. Leong AS, et al. Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221. Clin Mol Pathol. 1995. PMID: 16696013 Free PMC article. No abstract available. - Protein biomarkers for subtyping breast cancer and implications for future research.
Mueller C, Haymond A, Davis JB, Williams A, Espina V. Mueller C, et al. Expert Rev Proteomics. 2018 Feb;15(2):131-152. doi: 10.1080/14789450.2018.1421071. Epub 2018 Jan 3. Expert Rev Proteomics. 2018. PMID: 29271260 Free PMC article. Review. - Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status.
Tsakountakis N, Sanidas E, Stathopoulos E, Kafousi M, Anogiannaki N, Georgoulias V, Tsiftsis DD. Tsakountakis N, et al. BMC Womens Health. 2005 Feb 4;5(1):1. doi: 10.1186/1472-6874-5-1. BMC Womens Health. 2005. PMID: 15694000 Free PMC article. - HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer.
Singer CF, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Walter I, Hudelist G, Helmy S, Spiess AC, Lamm W, Kubista E. Singer CF, et al. J Cancer Res Clin Oncol. 2009 Jun;135(6):807-13. doi: 10.1007/s00432-008-0516-x. Epub 2008 Nov 26. J Cancer Res Clin Oncol. 2009. PMID: 19034514 - Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.
Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD. Marks JR, et al. Ann Surg. 1994 Apr;219(4):332-41. doi: 10.1097/00000658-199404000-00002. Ann Surg. 1994. PMID: 7909221 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous